Hera BioLabs
Objective
Hera BioLabs (Hera), a preclinical gene editing and animal service CRO, with a growing cell line development offering, was seeking an experienced life sciences marketing partner to expand and formalize their existing brand. Our goal was to modernize their brand, grow awareness through creative assets, and position them as a skilled team, adept at tailoring research solutions that aligned perfectly with customer needs.
Uniting the right elements to ExpandThe Brand
Branding: Hera’s gene editing technology and itsproprietary SRG RAT® helped the company garner a strong following in academicand industry labs. However, in preparation for the company’s expanded productand services offerings using its proprietary technology, it was the right timeto further amplify their presence and introduce a refreshed identity.
All good brands start with getting to know each other. Element CG conducted authentic conversations with key stakeholders and technical subject matter experts, reviewed background documentation, and analyzed competing companies. Guided by these insights, we developed a brand messaging framework and new visual design treatments to define Hera’s unique value in a formalized Brand Style Board.
Digital: Websites are a brand’s foundation for digital success and a top priority during the brand refresh process.Element CG is systematically working to refine the messaging and visual design of Hera’s website and brought the new identity to life on the redesigned Homepage.
Creative: Hera was in a position to introduce its evolving brand and highlight its proprietary SRG Rat at the Society ofToxicology and American Association of Cancer Research annual meetings this year. To support this, Element CG lead the development and design of social media posts, a 10-foot portable booth, and several refreshed brochures that expanded on the recently formalized verbal and visual branding.
“I love it. It makes me so happy! Please tell your designer and team thanks for the hard work.” - Head of BD
Meet Hera Biolabs:
Hera Biolabs is leveraging cutting-edge gene editing technologies, featured in 800+ peer-reviewed papers, to bring novel models and cell-line engineering to drug development researchers. See how their experienced team,US-based facilities, and portfolio of sophisticated tools and services accelerate drug discovery and development at www.herabiolabs.com.